Cambridge-based AVEO Raises $100M and Needs Talent!
0 followers
0 Likes
Cambridge, Mass. -- AVEO Pharmaceuticals, a Cambridge-based company, has priced a secondary public offering of stock to raise about $100 million. The company sold about 5.8 million shares priced at $17.50 per share in the deal. Founded in 2001, AVEO Pharmaceuticals is focused on discovering, developing and commercializing targeted therapies to treat cancer.
0 Replies
Reply
Subgroup Membership is required to post Replies
Join Better Jobs Faster now
Suggested Posts
| Topic | Replies | Likes | Views | Participants | Last Reply |
|---|---|---|---|---|---|
| Be Self-Employed Writing Content | 0 | 0 | 292 | ||
| Work from Home Writing Articles | 0 | 0 | 120 | ||
| Band Together Seeks New Executive Director in Raleigh Area | 0 | 0 | 525 |